首页> 外国专利> DENDRITIC HUMAN UNIVERSAL NON-ANTIGEN EDUCAP VACCINE

DENDRITIC HUMAN UNIVERSAL NON-ANTIGEN EDUCAP VACCINE

机译:树突式人民通用非抗原教育疫苗

摘要

A non-antigenic microRNA exosomal vaccination that includes dendritic-derived exosomes resulting from the incubation of dendritic cells with Spike Protein of a COVID-19 virus so that the dendritic cells process the Spike Protein of the COVID-19 virus to enable education of naïve T-cells. The exosomes so-derived are then harvested and encapsulated for delayed release oral capsule delivery to selectively reach intestinal antigen-presenting cells in the terminal ileum for stimulating an acquired immune response to the Spike Protein of the COVID-19 virus. The intestinal antigen-presenting cells incorporate the dendritic-derived exosomes, and thereby learn to recognize the Spike Protein as a threat, even though no dangerous antigens, RNA, or DNA modifications of the antigen or Spike Protein of the COVID-19 virus were introduced by the non-antigenic microRNA exosomal vaccine, thereby avoiding creation of new pandemic viral emergencies, cytokine storms, mitochondrial aerobic failure, serious illnesses, and death via mutated strains of the COVID-19 virus.
机译:其包括从树突状细胞与COVID-19病毒的刺突蛋白的温育所得树突衍生的外来体的非抗原性微RNA外来体接种,使得树突细胞处理COVID-19病毒的刺突蛋白,使幼稚T的教育-细胞。然后如此衍生的外来体收获并封装为延迟释放口服胶囊递送至在回肠末端选择性地到达肠道的抗原呈递细胞刺激到COVID-19病毒的刺突蛋白的获得性免疫应答。肠道抗原呈递细胞包括树突状衍生的外来体,并由此学会识别S蛋白是一种威胁,即使没有危险的抗原,所述COVID-19病毒的抗原或纤突蛋白的RNA或DNA修饰引入由非抗原性的microRNA的外来体疫苗,从而通过COVID-19病毒突变株避免新的大流行病毒的紧急情况,细胞因子风暴,线粒体有氧故障,严重的疾病和死亡的创建。

著录项

  • 公开/公告号US2022016163A1

    专利类型

  • 公开/公告日2022-01-20

    原文格式PDF

  • 申请/专利权人 WILLIAM RICHARD DEAGLE;

    申请/专利号US202016948930

  • 发明设计人 WILLIAM RICHARD DEAGLE;

    申请日2020-10-06

  • 分类号A61K35/15;C12N5/0784;

  • 国家 US

  • 入库时间 2022-08-24 23:24:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号